Trends in epidemiology and treatment and outcome for head and neck cancer: A population-based long-term analysis from 1996 to 2011 of the Thuringian cancer registry

Oral Oncology

Volumn 50, Issue 12, 2014, Pages 1157-1164

  Guntinas Lichius, Orlando ^a   Wendt, Thomas G ^a   Kornetzky, Nicole ^a   Buentzel, Jens ^b   Esser, Dirk ^c   Böger, Daniel ^b   Müller, Andreas ^d   Schultze Mosgau, Stefan ^a   Schlattmann, Peter ^a   Schmalenberg, Harald ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b Suedharzkrankenhaus Nordhausen ^*  (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d SRH Wald Klinikum Gera   (Germany)

Author keywords

Cancer registry; Elderly; Epidemiology; Head and neck neoplasm; Risk; Survival

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CETUXIMAB; TAXANE DERIVATIVE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL OBSERVATION; COHORT ANALYSIS; FEMALE; GERMANY; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LIP CANCER; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MOUTH CANCER; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CANCER; NOSE CANCER; OROPHARYNX CANCER; OVERALL SURVIVAL; PARANASAL SINUS CANCER; PATIENT IDENTIFICATION; POPULATION RESEARCH; SALIVARY GLAND CANCER; TREATMENT OUTCOME; TREND STUDY; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; INCIDENCE; LARYNGEAL NEOPLASMS; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; RISK FACTOR; SURVIVAL; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84913602526     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.09.015     Document Type: Article

References (35)

1. D. Pulte, and H. Brenner Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis Oncologist 15 2010 994 1001
2. C.P. Rodriguez, and D.J. Adelstein Survival trends in head and neck cancer: opportunities for improving outcomes Oncologist 15 2010 921 923
3. H.T. Hoffman, K. Porter, L.H. Karnell, J.S. Cooper, R.S. Weber, and C.J. Langer Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival Laryngoscope 116 2006 1 13
4. C.D. Fuller, S.J. Wang, C.R. Thomas Jr.; H.T. Hoffman, R.S. Weber, and D.I. Rosenthal Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998 Cancer 109 2007 1331 1343
5. J.S. Cooper, K. Porter, K. Mallin, H.T. Hoffman, R.S. Weber, and K.K. Ang National Cancer Database report on cancer of the head and neck: 10-year update Head Neck 31 2009 748 758
6. J.P. Klussmann, S.J. Weissenborn, U. Wieland, V. Dries, J. Kolligs, and M. Jungehuelsing Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas Cancer 92 2001 2875 2884
7. S. Marur, and A.A. Forastiere Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer Curr Opin Oncol 22 2010 206 211
8. B.M. Lin, H. Wang, G. D'Souza, Z. Zhang, C. Fakhry, and A.W. Joseph Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma Cancer 119 2013 3462 3471
9. E.G. Sarris, K.J. Harrington, M.W. Saif, and K.N. Syrigos Multimodal treatment strategies for elderly patients with head and neck cancer Cancer Treat Rev 40 2014 465 475
10. L. Talarico, G. Chen, and R. Pazdur Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration J Clin Oncol 22 2004 4626 4631
11. N. Bhattacharyya A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly Laryngoscope 113 2003 368 372
12. F. Siddiqui, and C.K. Gwede Head and neck cancer in the elderly population Semin Radiat Oncol 22 2012 321 333
13. J.H. Lorch, M.R. Posner, L.J. Wirth, and R.I. Haddad Induction chemotherapy in locally advanced head and neck cancer: a new standard of care Hematol Oncol Clin North Am 22 2008 1155 1163 viii
14. S. Schmitz, K.K. Ang, J. Vermorken, R. Haddad, C. Suarez, and G.T. Wolf Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions Cancer Treat Rev 40 2014 390 404
15. C. Cripps, E. Winquist, M.C. Devries, D. Stys-Norman, and R. Gilbert Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer Curr Oncol 17 2010 37 48
16. M.P. Mak, W.N. William, and Jr Targeting the epidermal growth factor receptor for head and neck cancer chemoprevention Oral Oncol 2014 [Epub ahead of print]
17. O. Guntinas-Lichius, T. Wendt, J. Buentzel, D. Esser, P. Lochner, and A. Mueller Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database J Cancer Res Clin Oncol 136 2010 55 63
18. R. Stabenow, M. Schulz, and B. Streller Krebs in Thüringen 2002-2004 2007 KAJA Druck & Verlag Werder/Havel
19. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International Classification of Diseases for Oncology (ICD-O). 3rd ed. Geneva: World Health Organization, 2000.
20. A.L. Kruse, M. Bredell, H.T. Luebbers, and K.W. Gratz Head and neck cancer in the elderly: a retrospective study over 10 years (1999-2008) Head Neck Oncol 2 2010 25
21. B.J. Braakhuis, C.R. Leemans, and O. Visser Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011 Oral Oncol 50 2014 670 675
22. E. Suarez, W.A. Calo, E.Y. Hernandez, E.C. Diaz, N.R. Figueroa, and A.P. Ortiz Age-standardized incidence and mortality rates of oral and pharyngeal cancer in Puerto Rico and among Non-Hispanics Whites, Non-Hispanic Blacks, and Hispanics in the USA BMC Cancer 9 2009 129
23. M.A. O'Rorke, M.V. Ellison, L.J. Murray, M. Moran, J. James, and L.A. Anderson Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis Oral Oncol 48 2012 1191 1201
24. V. Paleri, R.G. Wight, C.E. Silver, M. Haigentz Jr, R.P. Takes, and P.J. Bradley Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice Oral Oncol 46 2010 712 719
25. C. Dansky Ullmann, L.C. Harlan, V.L. Shavers, and J.L. Stevens A population-based study of therapy and survival for patients with head and neck cancer treated in the community Cancer 118 2012 4452 4461
26. J.A. Bonner, P.M. Harari, J. Giralt, N. Azarnia, D.M. Shin, and R.B. Cohen Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 2006 567 578
27. M. Posner, and J.B. Vermorken Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer Semin Oncol 35 2008 22128
28. J. Bernier, and J.S. Cooper Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist 10 2005 215 224
29. M.R. Posner, D.M. Hershock, C.R. Blajman, E. Mickiewicz, E. Winquist, and V. Gorbounova Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715
30. J.P. Pignon, A. le Maitre, E. Maillard, and J. Bourhis Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
31. P. Brocklehurst, O. Kujan, A.M. Glenny, R. Oliver, P. Sloan, and G. Ogden Screening programmes for the early detection and prevention of oral cancer Cochrane Database Syst Rev 2010 CD004150
32. B. Ansa, M. Goodman, K. Ward, S.A. Kono, T.K. Owonikoko, and K. Higgins Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973-2009 Cancer 119 2013 2602 2610
33. J.A. Reizenstein, L. Holmberg, M. Bergqvist, A. Linder, S. Ekman, and B. Lödén Time trends in T3-T4 laryngeal cancer: a population-based long-term analysis Head Neck 2013 [Epub ahead of print]
34. M.S. Tiwana, J. Wu, J. Hay, F. Wong, W. Cheung, and R.A. Olson 25 Year survival outcomes for squamous cell carcinomas of the head and neck: population-based outcomes from a Canadian province Oral Oncol 50 2014 651 656
35. B.A. van Dijk, H.E. Karim-Kos, J.W. Coebergh, H.A. Marres, and E. de Vries Progress against laryngeal cancer in The Netherlands between 1989 and 2010 Int J Cancer 134 2014 674 681